Search Result7items

Eight markers, multiplex immunofluorescent staining

NanoZoomer S60 contributes to the ability to perform 8 established staining’s on multiple individual single sections, with a turnaround time compatible with clinical needs.

FISHing of gut microbiota – microbiology in health and diseases

BIOASTER Technology Research Institute (TRI) drives developments in a unique technological and innovative model in order to overcome technological bottlenecks and explore new avenues applied to microbiology in health and disease

Quantifying virtual co-localization of tissue-based biomarkers

Whole slide imaging proves to be essential in achieving an integrated solution, ensuring the analysis and validation of tissue-based biomarkers.

Unveiling the cellular distribution of two fluorescent receptors

Dr Dominique Massotte, Department of Neurogenetics and Translational Medicine, IGBMC, pioneered the creation of a virtual atlas presenting the distribution of two fluorescent receptors in the mouse brain, the mu and delta opioid receptors.

Advancing histology and pathophysiology of bone

In 2011, Pathophysiology of Bone Resorption Laboratory acquired a digital slide scanner, the Hamamatsu NanoZoomer 2.0-RS to contribute to research in molecular and cellular mechanisms involved in the pathogenesis of bone tumours.

Digital slide scanning contributes to breast cancer research

Glasgow University implements NanoZoomer digital slide scanner, TMA and Image Analysis Unit facilitating research in the investigation of cancers of the skin, colorectal cancer, prostate cancer, melanomas, colon cancer, breast cancer, pancreatic cancers and bone disorders.

Tumour detection in Fluorescent Tissue Microarrays

Whole slide imaging (WSI) contributes to a method of being able to distinguish between tumour and stroma tissue with a total overall accuracy of 88%.

Scroll to Top